Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of new biomarkers for malignant mesothelioma

31 Jan 2015

Abstract excerpt

Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been approved by the US FDA primarily as a tool for monitoring patient response and progression. Mesothelin is elevated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Occupational and environmental lung diseases
Share to Occupational exposure and asthma
Share to Pleural and Pulmonary Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25927434
DOI: 10.1007/s13665-015-0106-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of new biomarkers for malignant mesotheliomaPMID 25927434Read ↗

Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.Semantic proximity Read ↗

Progress and challenges in Mesothelioma: From bench to bedside.Semantic proximity Read ↗

Towards a Better Understanding of Mesothelioma: A Comprehensive Review of Diagnosis, Therapy and BiomarkersSemantic proximity Read ↗

Biological basis for novel mesothelioma therapiesSemantic proximity Read ↗

Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma DiagnosisSemantic proximity Read ↗

Genomics and Epigenetics of Malignant MesotheliomaSemantic proximity Read ↗

Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance ToolSemantic proximity Read ↗

Cellular and molecular parameters of mesotheliomaSemantic proximity Read ↗

Artichoke Phytocomplex Modulates Serum microRNAs in Patients Exposed to Asbestos: A First Step of a Phase II Clinical TrialSemantic proximity Read ↗

Mesothelioma: recent highlightsSemantic proximity Read ↗

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workersSemantic proximity Read ↗

Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.